Director/PDMR Shareholding

RNS Number : 7517A

Allergy Therapeutics PLC

14 October 2009

 



Wednesday 14 October 2009 

Allergy Therapeutics plc

('Allergy Therapeutics' or the 'Company')

Director/PDMR Shareholding

Allergy Therapeutics announces that on 8 October 2009 the Company received notification that on 30 September 2009 Mr Keith Carter, a director of the Company, exercised share options over 175,000 ordinary shares of 0.1 pence each ('Ordinary Shares') awarded pursuant to the Allergy Therapeutics 2001 Share Option Plan as follows:

Name of scheme:	Allergy Therapeutics 2001 Share Option Plan
Date of grant:	18 December 2002
Date of exercise:	12 October 2009
Exercise price:	5.0 pence
Number of shares exercised:	175,000

Following the above transactions Mr Carter now holds share options over 1,487,654 Ordinary Shares. In addition Mr Carter holds 3,347,669 Ordinary Shares, representing 1.15 per cent. of the total voting rights of the Company.

Application has been made for the admission to trading on AIM ("Admission") of 175,000 Ordinary Shares at nominal value with Admission expected to take place on 20 October 2009.

For further information

Allergy Therapeutics	[phone]
Ian Postlethwaite, Finance Director
www.allergytherapeutics.com
Nomura Code Securities	[phone]
Juliet Thompson/ Clare Terlouw

 

END

 

 

RDSGCBDGCUBGGCS